Metraipolis › archive › dc_59dfef1b3d64

Impact of Leukapheresis and Biological Risk Markers on Early Mortality in Patients with Hyperleukocytic Acute Myeloid Leukemia — Europe PMC PMID:41597321

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41597321
DOI
10.3390/medicina62010035
License (as archived)
solo-consultazione
Archived
2026-11-07T10:39:58.680Z
SHA-256 of the archived text
ccbf4e256edcbccc84d24f6a174d384c7b05bbce1851d513f2e811c2a4114600
Stable URL of this page
https://metraipolis.com/documento/dc_59dfef1b3d64

How to cite

Impact of Leukapheresis and Biological Risk Markers on Early Mortality in Patients with Hyperleukocytic Acute Myeloid Leukemia — Europe PMC PMID:41597321 — Europe PMC (en), https://europepmc.org/article/MED/41597321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_59dfef1b3d64 (Metraipolis archive dc_59dfef1b3d64, sha256 ccbf4e256edcbccc84d24f6a174d384c7b05bbce1851d513f2e811c2a4114600)
BibTeX
@misc{dc59dfef1b3d64,
  title = {Impact of Leukapheresis and Biological Risk Markers on Early Mortality in Patients with Hyperleukocytic Acute Myeloid Leukemia — Europe PMC PMID:41597321},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41597321},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_59dfef1b3d64; sha256 ccbf4e256edcbccc84d24f6a174d384c7b05bbce1851d513f2e811c2a4114600},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41597321. Agents can read the archived copy with the MCP tool read_document.